Impax Asset Management Group plc reduced its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 5.5% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 331,445 shares of the medical device company’s stock after selling 19,420 shares during the period. Impax Asset […]
Impax Asset Management Group plc reduced its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 5.5% during the second quarter, HoldingsChannel reports. The firm owned 331,445 shares of the medical device company’s stock after selling 19,420 shares during the quarter. Impax Asset Management Group plc’s holdings in DexCom were worth $42,594,000 at the end […]
Perigon Wealth Management LLC bought a new position in DexCom, Inc. (NASDAQ:DXCM – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,853 shares of the medical device company’s stock, valued at approximately $238,000. Other hedge funds and other institutional […]
NorthRock Partners LLC decreased its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 9.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,203 shares of the medical device company’s stock after selling 335 shares during the quarter. NorthRock Partners […]
Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have received a consensus rating of “Moderate Buy” from the sixteen analysts that are presently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation, thirteen have given a buy recommendation and one has issued a strong buy recommendation […]